Monday, Jul 1, 2024 · SEC filings
What the smart money revealed on Jul 1
710 insider filings came in. We hid 53 planned (10b5-1) sellers and 591 people whose filings were routine, like grants and tax withholding.
Eliem Therapeutics (CLYM) Director Peter Kolchinsky bought $50M
13.01M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Globalstar (GSAT) Director James Monroe III bought $4.78M
4.51M shares on the open market. Not a grant or an option exercise.
Kronos Bio (KRON) President and CEO Norbert Bischofberger bought $737K
615,518 shares on the open market. Not a grant or an option exercise.
StepStone Private Credit Income Fund Pres. and Prin. Exec. Officer Robert Long bought $500K
49,801 shares on the open market. Not a grant or an option exercise.
CCC Intelligent Solutions (CCC) Director Lauren Young sold $282M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 139.34M shares.
FedEx (FDX) EVP Genl Counsel/secty Mark Allen sold $23M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 34,965 shares directly.
High Income Securities Fund (PCF) Director Phillip Goldstein sold $624K
Not marked as a planned 10b5-1 sale. Sold 90% of the shares they held directly. Still holds 9,773 shares.
Show 25 more real buys
Show 12 more real sales
13F season
Holdings as of Jun 30, 2024 are due Aug 14
54 funds have filed so far. 50 filed for the quarter before.
Biggest real insider buys, Jun 25–Jul 1
Open-market buys by officers and directors, filed in the 7 days up to Jul 1.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.